Bmi‐1, through the induction of phosphorylation of IKKb and IκBa and co‐localization with the catalytic subunit of NF‐κB in the cell nucleus of tumor cells, activates NF‐κB and renders glioma cells resistant to cytotoxic treatments [53]. The gene discussed is NFKB1; the disease is neoplasm.